Presentation THT 2024 Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock Presenter: James W. Schurr March 06, 2024
Presentation THT 2024 The Conundrum of Clinical Trials in Cardiogenic Shock Presenter: JoAnn Lindenfeld March 06, 2024
Presentation THT 2024 Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways? Presenter: Mariell Jessup March 05, 2024
Presentation THT 2024 Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers Presenter: Harriette G.C. Van Spall March 05, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
Presentation THT 2024 Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond Presenter: Sean P. Pinney March 04, 2024
Presentation THT 2024 Reducing Congestion by Removing Fluid From the Interstitium Presenter: William T. Abraham March 04, 2024
Presentation THT 2024 Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins Presenter: Ulrich P. Jorde March 04, 2024
Presentation THT 2024 Early Experience With Devices That Increase Kidney Perfusion From the Aorta Presenter: Jennifer A. Cowger March 04, 2024
Presentation THT 2024 Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials Presenter: James Januzzi March 04, 2024
Presentation THT 2024 Contemporary Pharmacological Therapies for Acute Heart Failure Presenter: Wilfried Mullens March 04, 2024
News Daily News Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial Todd Neale March 04, 2024
News Daily News Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry Caitlin E. Cox March 01, 2024
News Daily News Living Near Bars, Restaurants Linked to Greater Likelihood of HF L.A. McKeown February 29, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News Niacin, When Broken Down by the Body, Can Spur Inflammation Caitlin E. Cox February 22, 2024